Zein nanoparticles stabilized by hydrophilic small molecule stabilizer matrine deliver curcumin effectively

Matrine (MAR), a quinolone alkaloid, was employed to augment the stability of zein nanoparticles. The incorporation of MAR into the hydrophobic shell of zein nanoparticles was primarily achieved through hydrogen bonding. Curcumin (CUR), a hydrophobic active substance, was encapsulated in the hydrophobic core of zein/matrine nanoparticles (ZMNPs). The preparation of ZMNPs and curcumin-loaded zein/matrine nanoparticles (CZMNPs) was accomplished using an antisolvent precipitation method. The encapsulation efficiency of curcumin in ZMNPs (zein/MAR = 8:1, 20 mg zein and 2.5 mg matrine) was significantly greater (52.64%) than that of nanoparticles produced from a single zein (2.50%). CZMNPs demonstrated a notable encapsulation efficiency and loading capacity (88.30% and 7.84%, respectively) upon the addition of 2 mg of curcumin, and were capable of sustained and gradual release of curcumin in simulated intestinal fluid. Furthermore, the stability of ZMNPs was observed to be favorable across a range of environmental conditions, including pH levels of 2-4 and 6-9, salt concentrations of & LE;150 mM, temperatures of & LE;90 & DEG;C, and storage at room temperature for a duration of 30 days. Additionally, the inherent anti-cancer properties of MAR make CZMNPs a more efficacious inhibitor of tumor cell proliferation in vitro. Moreover, the uptake of CZMNPs by A549 cells was significantly enhanced, potentially through the process of endocytosis. Therefore, the incorporation of matrine in zein-based nanoparticles confers anticancer properties to the resulting ZMNPs. These nanoparticles can serve as encapsulating agents for bioactive compounds in pharmaceutical formulations and as a novel delivery strategy for long-term cancer care. Specifically, matrine is anticipated to function as a potential stabilizer for other nanosystems.